Aplisens is selling at 17.60 as of the 27th of November 2024; that is 7.12% down since the beginning of the trading day. The stock's lowest day price was 17.6. Aplisens has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Aplisens SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of May 2024 and ending today, the 27th of November 2024. Click here to learn more.
Although Aplisens' alpha and beta are two of the key measurements used to evaluate Aplisens' performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aplisens stock to make a market-neutral strategy. Peer analysis of Aplisens could also be used in its relative valuation, which is a method of valuing Aplisens by comparing valuation metrics with similar companies.
When running Aplisens' price analysis, check to measure Aplisens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aplisens is operating at the current time. Most of Aplisens' value examination focuses on studying past and present price action to predict the probability of Aplisens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aplisens' price. Additionally, you may evaluate how the addition of Aplisens to your portfolios can decrease your overall portfolio volatility.